mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.03 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |